{"AllianceGenome": "171", "HGNC": "171", "MIM": "102576", "_id": "90", "_version": 2, "accession": {"genomic": ["A38807.1", "AC013731.10", "AC019186.9", "CH471058.2", "CP068276.2", "HB448223.1", "HI574330.1", "HM015588.1", "KM873050.1", "NC_000002.12", "NC_060926.1", "NG_008004.1"], "protein": ["AAA36614.1", "AAH33867.1", "AAY15094.1", "AAY24272.1", "ADL14509.1", "AJF45349.1", "ALQ33343.1", "ALQ33344.1", "ALQ33345.1", "BAG60113.1", "CAA02405.1", "CAA80256.1", "CAZ91465.1", "CBX47654.1", "EAX11438.1", "EAX11439.1", "EAX11440.1", "EAX11441.1", "EAX11442.1", "EAX11443.1", "NP_001096.1", "NP_001104537.1", "NP_001334592.1", "NP_001334593.1", "NP_001334594.1", "NP_001334595.1", "NP_001334596.1", "Q04771.1"], "rna": ["AK297765.1", "AK313630.1", "BC033867.1", "BC036748.1", "DA796090.1", "DB270850.1", "KU177885.1", "KU177886.1", "KU177887.1", "L02911.1", "NM_001105.5", "NM_001111067.4", "NM_001347663.1", "NM_001347664.1", "NM_001347665.1", "NM_001347666.1", "NM_001347667.2", "Z22534.1"], "translation": [{"protein": "NP_001334593.1", "rna": "NM_001347664.1"}, {"protein": "BAG60113.1", "rna": "AK297765.1"}, {"protein": "ALQ33343.1", "rna": "KU177885.1"}, {"protein": "NP_001334594.1", "rna": "NM_001347665.1"}, {"protein": "NP_001334595.1", "rna": "NM_001347666.1"}, {"protein": "NP_001104537.1", "rna": "NM_001111067.4"}, {"protein": "NP_001334592.1", "rna": "NM_001347663.1"}, {"protein": "CAA80256.1", "rna": "Z22534.1"}, {"protein": "ALQ33345.1", "rna": "KU177887.1"}, {"protein": "AAA36614.1", "rna": "L02911.1"}, {"protein": "NP_001096.1", "rna": "NM_001105.5"}, {"protein": "ALQ33344.1", "rna": "KU177886.1"}, {"protein": "AAH33867.1", "rna": "BC033867.1"}, {"protein": "NP_001334596.1", "rna": "NM_001347667.2"}]}, "alias": ["ACTRI", "ACVR1A", "ACVRLK2", "ALK2", "FOP", "SKR1", "TSRI"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "limited", "classification_date": "2023-08-14T16:00:00.000Z", "disease_label": "congenital heart disease", "gcep": "Congenital Heart Disease Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0005453", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a34f19aa-a12e-483c-ae09-a0fce770647b-2023-08-14T160000.000Z", "sop": "SOP9"}, {"classification": "definitive", "classification_date": "2023-03-01T17:00:00.000Z", "disease_label": "fibrodysplasia ossificans progressiva", "gcep": "Skeletal Disorders Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0007606", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0439e75f-fc1b-4841-8c9a-17f3568ce8a4-2023-03-01T170000.000Z", "sop": "SOP10"}]}, "ec": "2.7.11.30", "ensembl": {"gene": "ENSG00000115170", "protein": ["ENSP00000263640", "ENSP00000387127", "ENSP00000387273", "ENSP00000399322", "ENSP00000400767", "ENSP00000401189", "ENSP00000403006", "ENSP00000405004", "ENSP00000440091", "ENSP00000500109", "ENSP00000500605", "ENSP00000506824", "ENSP00000507086", "ENSP00000507102", "ENSP00000507113", "ENSP00000507597", "ENSP00000507727", "ENSP00000507730", "ENSP00000508136", "ENSP00000508189"], "transcript": ["ENST00000263640", "ENST00000409283", "ENST00000410057", "ENST00000412025", "ENST00000413751", "ENST00000424669", "ENST00000434821", "ENST00000440523", "ENST00000487456", "ENST00000539637", "ENST00000672582", "ENST00000673324", "ENST00000681995", "ENST00000682025", "ENST00000682300", "ENST00000682690", "ENST00000683404", "ENST00000683426", "ENST00000683441", "ENST00000683487", "ENST00000683514", "ENST00000683820", "ENST00000684104", "ENST00000684348", "ENST00000684567", "ENST00000684595"], "translation": [{"protein": "ENSP00000507086", "rna": "ENST00000682025"}, {"protein": "ENSP00000507113", "rna": "ENST00000683487"}, {"protein": "ENSP00000507102", "rna": "ENST00000682300"}, {"protein": "ENSP00000508189", "rna": "ENST00000683441"}, {"protein": "ENSP00000507730", "rna": "ENST00000684595"}, {"protein": "ENSP00000263640", "rna": "ENST00000263640"}, {"protein": "ENSP00000506824", "rna": "ENST00000683404"}, {"protein": "ENSP00000507597", "rna": "ENST00000683426"}, {"protein": "ENSP00000405004", "rna": "ENST00000434821"}, {"protein": "ENSP00000387273", "rna": "ENST00000409283"}, {"protein": "ENSP00000507727", "rna": "ENST00000683820"}, {"protein": "ENSP00000508136", "rna": "ENST00000684348"}, {"protein": "ENSP00000500605", "rna": "ENST00000672582"}, {"protein": "ENSP00000500109", "rna": "ENST00000673324"}, {"protein": "ENSP00000400767", "rna": "ENST00000424669"}, {"protein": "ENSP00000440091", "rna": "ENST00000539637"}, {"protein": "ENSP00000387127", "rna": "ENST00000410057"}, {"protein": "ENSP00000403006", "rna": "ENST00000412025"}, {"protein": "ENSP00000401189", "rna": "ENST00000440523"}, {"protein": "ENSP00000399322", "rna": "ENST00000413751"}], "type_of_gene": "protein_coding"}, "entrezgene": "90", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 18.35127405, "exp_mis": 174.9026385, "exp_syn": 78.519021, "lof_z": 3.78101274812235, "mis_z": 2.5853040577676, "mu_lof": 1.28677293652e-06, "mu_mis": 1.51039379274e-05, "mu_syn": 6.59715582507e-06, "n_lof": 2.0, "n_mis": 105.0, "n_syn": 72.0, "p_li": 0.95644819340706, "p_null": 4.53001157960967e-06, "p_rec": 0.0435472765813608, "syn_z": 0.456083461164927}, "bp": 1530, "cds_end": 158656005, "cds_start": 158594042, "n_exons": 9, "nonpsych": {"exp_lof": 16.4239537, "exp_mis": 158.1180497, "exp_syn": 70.8815714, "lof_z": 3.495404395829, "mis_z": 2.73232826249832, "mu_lof": 1.28677293652e-06, "mu_mis": 1.51039379274e-05, "mu_syn": 6.59715582507e-06, "n_lof": 2.0, "n_mis": 90.0, "n_syn": 66.0, "p_li": 0.924418826897715, "p_null": 2.22059119157533e-05, "p_rec": 0.0755589671903689, "syn_z": 0.365053355472619}, "nontcga": {"exp_lof": 16.86506994, "exp_mis": 160.8923362, "exp_syn": 72.21940029, "lof_z": 3.57070679753778, "mis_z": 2.31313487868884, "mu_lof": 1.28677293652e-06, "mu_mis": 1.51039379274e-05, "mu_syn": 6.59715582507e-06, "n_lof": 2.0, "n_mis": 102.0, "n_syn": 66.0, "p_li": 0.929174566834179, "p_null": 1.54011499065369e-05, "p_rec": 0.0708100320159145, "syn_z": 0.463386993286637}, "transcript": "ENST00000263640.3"}, "exons": [{"cdsend": 157799493, "cdsstart": 157737530, "chr": "2", "position": [[157736445, 157737665], [157738439, 157738570], [157760879, 157761077], [157765920, 157766196], [157770367, 157770514], [157774087, 157774187], [157778130, 157778342], [157780336, 157780600], [157799426, 157799500], [157818384, 157818559], [157874863, 157874999]], "strand": -1, "transcript": "NM_001105", "txend": 157874999, "txstart": 157736445}, {"cdsend": 157799493, "cdsstart": 157737530, "chr": "2", "position": [[157736445, 157737665], [157738439, 157738570], [157760879, 157761077], [157765920, 157766196], [157770367, 157770514], [157774087, 157774187], [157778130, 157778342], [157780336, 157780600], [157799426, 157799500], [157818384, 157818559], [157875795, 157876330]], "strand": -1, "transcript": "NM_001111067", "txend": 157876330, "txstart": 157736445}, {"cdsend": 157799493, "cdsstart": 157737530, "chr": "2", "position": [[157736445, 157737665], [157738439, 157738570], [157760879, 157761077], [157765920, 157766196], [157770367, 157770514], [157774087, 157774187], [157778130, 157778342], [157780336, 157780600], [157799426, 157799500], [157818384, 157818559], [157875741, 157875862]], "strand": -1, "transcript": "NM_001347663", "txend": 157875862, "txstart": 157736445}, {"cdsend": 157799493, "cdsstart": 157737530, "chr": "2", "position": [[157736445, 157737665], [157738439, 157738570], [157760879, 157761077], [157765920, 157766196], [157770367, 157770514], [157774087, 157774187], [157778130, 157778342], [157780336, 157780600], [157799426, 157799500], [157818384, 157818559], [157826527, 157826646], [157875795, 157875862]], "strand": -1, "transcript": "NM_001347664", "txend": 157875862, "txstart": 157736445}, {"cdsend": 157799493, "cdsstart": 157737530, "chr": "2", "position": [[157736445, 157737665], [157738439, 157738570], [157760879, 157761077], [157765920, 157766196], [157770367, 157770514], [157774087, 157774187], [157778130, 157778342], [157780336, 157780600], [157799426, 157799500], [157818384, 157818559], [157819402, 157819489], [157875795, 157875862]], "strand": -1, "transcript": "NM_001347665", "txend": 157875862, "txstart": 157736445}, {"cdsend": 157799493, "cdsstart": 157737530, "chr": "2", "position": [[157736445, 157737665], [157738439, 157738570], [157760879, 157761077], [157765920, 157766196], [157770367, 157770514], [157774087, 157774187], [157778130, 157778342], [157780336, 157780600], [157799426, 157799500], [157818384, 157818559], [157860032, 157860179], [157875795, 157875862]], "strand": -1, "transcript": "NM_001347666", "txend": 157875862, "txstart": 157736445}, {"cdsend": 157799493, "cdsstart": 157737530, "chr": "2", "position": [[157736445, 157737665], [157738439, 157738570], [157760879, 157761077], [157765920, 157766196], [157770367, 157770514], [157774087, 157774187], [157778130, 157778342], [157780336, 157780600], [157799426, 157799500], [157818384, 157818559], [157826527, 157826646], [157838240, 157838630]], "strand": -1, "transcript": "NM_001347667", "txend": 157838630, "txstart": 157736445}], "exons_hg19": [{"cdsend": 158656005, "cdsstart": 158594042, "chr": "2", "position": [[158592958, 158594177], [158594951, 158595082], [158617391, 158617589], [158622432, 158622708], [158626879, 158627026], [158630599, 158630699], [158634642, 158634854], [158636848, 158637112], [158655938, 158656012], [158674896, 158675071], [158731375, 158731511]], "strand": -1, "transcript": "NM_001105", "txend": 158731511, "txstart": 158592958}, {"cdsend": 158656005, "cdsstart": 158594042, "chr": "2", "position": [[158592958, 158594177], [158594951, 158595082], [158617391, 158617589], [158622432, 158622708], [158626879, 158627026], [158630599, 158630699], [158634642, 158634854], [158636848, 158637112], [158655938, 158656012], [158674896, 158675071], [158732307, 158732842]], "strand": -1, "transcript": "NM_001111067", "txend": 158732842, "txstart": 158592958}, {"cdsend": 158656005, "cdsstart": 158594042, "chr": "2", "position": [[158592958, 158594177], [158594951, 158595082], [158617391, 158617589], [158622432, 158622708], [158626879, 158627026], [158630599, 158630699], [158634642, 158634854], [158636848, 158637112], [158655938, 158656012], [158674896, 158675071], [158732253, 158732374]], "strand": -1, "transcript": "NM_001347663", "txend": 158732374, "txstart": 158592958}, {"cdsend": 158656005, "cdsstart": 158594042, "chr": "2", "position": [[158592958, 158594177], [158594951, 158595082], [158617391, 158617589], [158622432, 158622708], [158626879, 158627026], [158630599, 158630699], [158634642, 158634854], [158636848, 158637112], [158655938, 158656012], [158674896, 158675071], [158683039, 158683158], [158732307, 158732374]], "strand": -1, "transcript": "NM_001347664", "txend": 158732374, "txstart": 158592958}, {"cdsend": 158656005, "cdsstart": 158594042, "chr": "2", "position": [[158592958, 158594177], [158594951, 158595082], [158617391, 158617589], [158622432, 158622708], [158626879, 158627026], [158630599, 158630699], [158634642, 158634854], [158636848, 158637112], [158655938, 158656012], [158674896, 158675071], [158675914, 158676001], [158732307, 158732374]], "strand": -1, "transcript": "NM_001347665", "txend": 158732374, "txstart": 158592958}, {"cdsend": 158656005, "cdsstart": 158594042, "chr": "2", "position": [[158592958, 158594177], [158594951, 158595082], [158617391, 158617589], [158622432, 158622708], [158626879, 158627026], [158630599, 158630699], [158634642, 158634854], [158636848, 158637112], [158655938, 158656012], [158674896, 158675071], [158716544, 158716691], [158732307, 158732374]], "strand": -1, "transcript": "NM_001347666", "txend": 158732374, "txstart": 158592958}, {"cdsend": 158656005, "cdsstart": 158594042, "chr": "2", "position": [[158592958, 158594177], [158594951, 158595082], [158617391, 158617589], [158622432, 158622708], [158626879, 158627026], [158630599, 158630699], [158634642, 158634854], [158636848, 158637112], [158655938, 158656012], [158674896, 158675071], [158683039, 158683158], [158694752, 158695142]], "strand": -1, "transcript": "NM_001347667", "txend": 158695142, "txstart": 158592958}], "generif": [{"pubmed": 11969340, "text": "distribution in gestational tissues across human pregnancy and during labour"}, {"pubmed": 16642017, "text": "We mapped fibrodysplasia ossificans progressiva to chromosome 2q23-24 by linkage analysis and identified an identical heterozygous mutation (617G --> A; R206H) in the glycine-serine (GS) activation domain of ACVR1"}, {"pubmed": 17351709, "text": "Study examined 3 Japanese patients with Fibrodysplasia ossificans progressiva for ACVR1 mutations and identified the 617G>A mutation in all 3 patients; results suggest that the mutation in the ACVR1 gene is common and recurrent in the global population."}, {"pubmed": 17496924, "text": "knockdown of ALK2, but not TGFbetaRI (ALK5), abrogated endoglin-mediated decreases in cell motility and constitutively active ALK2 was sufficient to restore a low-motility phenotype in endoglin deficient cells"}, {"pubmed": 17572636, "text": "In both the wild-type ACVR1 model and template crystal structures (TbetaRI), the conserved arginine appears to form a salt bridge with an invariant aspartate residue."}, {"pubmed": 18019378, "text": "Various mutations may occur in myositis ossificans nuclear families."}, {"pubmed": 18234825, "text": "Together, these findings show that TGFbeta superfamily activation of Smad2/3 is required for repression of spontaneous differentiation under strain."}, {"pubmed": 18292470, "text": "there was significant down-regulation of ALK-2 expression in asthma patients at baseline; allergy challenge was associated with upregulation"}, {"pubmed": 18684712, "text": "ALK2(R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or dorsomorphin."}, {"pubmed": 18830232, "text": "The novel amino-acid substitution is predicted to influence either the conformation/stability of the GS region or the binding affinity with FKBP12, resulting in a less stringent inhibitory control on the ACVR1 kinase activity."}, {"pubmed": 18854405, "text": "ALK2 signalling contributes to the disturbed folliculogenesis in polycystic ovary syndrome (PCOS) patients."}, {"pubmed": 18854405, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18952055, "text": "ALK2(G356D) activities found in Japanese fibrodysplasia ossificans progressiva patient were weaker than those of ALK2(R206H), and they were suppressed by a specific inhibitor of the BMP-regulated Smad pathway."}, {"pubmed": 19028479, "text": "The serum activin A level, increased in AMI, was positively correlated with peak CK and CK-MB levels which are measures of infarction size."}, {"pubmed": 19064572, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19085907, "text": "Study showed that all patients examined have heterozygous ACVR1 missense mutations in conserved amino acids."}, {"pubmed": 19148527, "text": "activin inhibits the growth of SNU-16 cells by inducing apoptosis through caspase activation."}, {"pubmed": 19299629, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19300893, "text": "This study aimed to investigate the ACVR1 gene mutation in Chinese FOP patients. Direct sequence analysis of genomic DNA and restriction enzyme digestion demonstrated the presence of a single heterozygous mutation in the ACVR1 gene in both patients."}, {"pubmed": 19330033, "text": "two further unique mutations (c.605G>T and c.983G>A) in this gene in two FOP patients; disparate missense mutations mapped to the GS and kinase domains of the protein supports the disease model of mild kinase activation"}, {"pubmed": 19335617, "text": "Data show that co-expressing constitutively active type I and type II receptors resulted in the phosphorylation of both R-Smad subclasses in a ligand-independent manner."}, {"pubmed": 19400542, "text": "NOG & 617G>A activin A type I receptor(ACVRI)mutations in 27 fibrodysplasia ossificans patients; 5 NOG mutations found in 7 patients; 617G>A mutation in ACVR1 gene found in 14 patients; with 1 exception, 617G>A & NOG mutations were mutually exclusive"}, {"pubmed": 19506109, "text": "Dominant-negative ALK2 allele associates with congenital heart defects."}, {"pubmed": 19543505, "text": "ACVR1 gene mutations were found heterozygous point mutation of c.617G>A; p.R206H in Myositis Ossificans."}, {"pubmed": 19574343, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19736306, "text": "Endoglin is phosphorylated on cytosolic domain threonine residues by the TGF-beta type I receptors ALK2 in prostate cancer cells. In the presence of constitutively active ALK2, endoglin did not inhibit cell migration"}, {"pubmed": 19796185, "text": "a variant of fibrodysplasia ossificans progressiva phenotypes are associated with specific mutations in ACVR1 gene"}, {"pubmed": 19896889, "text": "The discovery of the FOP metamorphogene reveals a highly conserved target for drug development and identifies a fundamental defect in the BMP signaling pathway that when triggered by injury and inflammation transforms one tissue into another."}, {"pubmed": 19929436, "text": "The R206H mutation in ALK2 confers constitutive activity to the mutant receptor, sensitizes mesenchymal cells to BMP-induced osteoblast differentiation, and stimulates new bone formation."}, {"pubmed": 19996292, "text": "BMP9 acts as a proliferative factor for immortalized ovarian surface epithelial cells and ovarian cancer cell lines, signaling predominantly through an ALK2/Smad1/Smad4 pathway, the major BMP9 receptor in endothelial cells."}, {"pubmed": 20011542, "text": "Of 51 microsatellite stable colon tumors, 7 (14%) lost ACVR2, 2 (4%) ACVR1, and 5 (10%) pSMAD2 expression."}, {"pubmed": 20463014, "text": "The impact of ACVR1 R206H mutation on BMP signaling and its downstream signaling cascades in murine myogenic C2C12 cells and HEK 293 cells, was studied."}, {"pubmed": 20577760, "text": "Progressive heterotopic ossification along with congenital malformation of the great toes, the two major clinical features that define classic FOP, led to a suspicion of FOP and to the definitive screening of the ACVR1 gene"}, {"pubmed": 20634197, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20677014, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20716560, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20736820, "text": "in two cases of fibrodysplasia ossificans progressiva, heterozygous missense mutation 617G>A (R206H) was found"}, {"pubmed": 21248739, "text": "These data indicate that in the context of a Down's syndrome background, ALK2-mediated reduction of BMP signaling may contribute to congenital heart defects."}, {"pubmed": 21297076, "text": "ACVR1 is associated with acute lung injury in mice"}, {"pubmed": 21377447, "text": "These findings suggest that ALK2(L196P) is an activated BMP receptor equivalent to ALK2(R206H) and that ALK2(L196P) activity may be suppressed in vivo by a novel molecular mechanism in fibrodysplasia ossificans progressiva patients with this mutation."}, {"pubmed": 21617230, "text": "Low activin A in the cytosol is associated with upper urinary tract urothelial carcinoma."}, {"pubmed": 21668474, "text": "copy number alterations at 2q24 can be involved in ACVR1 overexpression, which is associated with longer overall survival in laryngeal carcinomas"}, {"pubmed": 21878751, "text": "miR-30c expression was increased during adipogenesis of multipotent adipose-derived stem cells; miRNA target prediction revealed 2 putative direct targets of miR-30c, PAI-1 and ALK2, both inversely regulated to miR-30c during adipogenesis and responsive to miR-30c overexpression"}, {"pubmed": 22408438, "text": "miR-148a is an important mediator of ACVR1, thus offering a new potential target for the development of therapeutic agents against Fibrodysplasia ossificans progressiva."}, {"pubmed": 22630080, "text": "Fibrodysplasia ossificans progressiva has been linked to an autosomal dominant mutation on chromosome 2, to the gene encoding activin receptor-like kinase 2 (ALK2), a BMP type I receptor"}, {"pubmed": 22748444, "text": "Confirmation of the presence of this recurrent mutation facilitates diagnostic accuracy in affected persons in South Africa, and allows researchers to narrow the search for molecular targets for rational intervention to the ACVR1/ALK2 domain."}, {"pubmed": 22884369, "text": "Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo."}, {"pubmed": 22949078, "text": "Constitutive activation of ALK2 such as that caused by the Fibrodysplasia Ossificans Progressiva mutation inhibits the generation and maintenance of human induced pluripotent stem cells."}, {"pubmed": 22971142, "text": "Presence of the 455C allele of BMP4 and the 8474T allele of ACVR1 gene was significantly associated with decreased left ventricular ejection fraction (LVEF) (p=0.0004 and p=0.046, respectively)."}, {"pubmed": 22977237, "text": "The crystal structure of the cytoplasmic domain of ALK2 in complex with the inhibitors FKBP12 and dorsomorphin."}, {"pubmed": 23142694, "text": "ALK2 may be an important receptor in ET-1 production during BMPR2 knockdown"}, {"pubmed": 23169291, "text": "Study suggests that activin A contributes to the malignant phenotype of malignant pleural mesothelioma (MPM) cells via regulation of cyclin D and may represent a valuable candidate for therapeutic interference."}, {"pubmed": 23227223, "text": "Functional analysis of the 3'UTR region by Luciferase reporter assays showed that it plays an inhibitory role on ACVR1/Alk-2 gene expression."}, {"pubmed": 23260810, "text": "Disease causing mutations in the ACVR1 gene identified in Turkish patients diagnosed as fibrodysplasia ossificans progressiva."}, {"pubmed": 23918320, "text": "heterozygous mutation i.e., c.617(G>A)in ACVR1 was detected in patients with rare genetic disorder - Fibrodysplasia ossificans progressiva"}, {"pubmed": 24047559, "text": "The findings provide novel insights into the molecular mechanisms that regulate expression of the ACVR1 gene and that could be targets of new strategies for future therapeutic treatments."}, {"pubmed": 24347165, "text": "Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-beta signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts."}, {"pubmed": 24705250, "text": "Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma."}, {"pubmed": 24705251, "text": "Recurrent somatic mutations in ACVR1 found in diffuse intrinsic pontine gliomas."}, {"pubmed": 24705252, "text": "Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma."}, {"pubmed": 24705254, "text": "ACVR1 mutations in diffuse intrinsic pontine gliomas were constitutively activating, leading to SMAD phosphorylation and increased expression of the downstream activin signaling targets ID1 and ID2."}, {"pubmed": 24798338, "text": "ALK2 (R206H) mutation increases osteoclast formation through TGF-beta. The activation of activin-like kinase signaling enhanced osteoclast formation through TGF-beta expression during heterotopic ossification in muscle tissues."}, {"pubmed": 25101911, "text": "compounds demonstrated consistent binding to a panel of mutant and wild-type ALK2 proteins"}, {"pubmed": 25271001, "text": "clinically aggressive stem cell-like subtype of hepatocellular carcinoma characterized by miR-148a-ACVR1-BMP-Wnt circuit"}, {"pubmed": 26058333, "text": "Genetic analysis of ACVR1 identified the recurrent allelic variant c.617 G>A; p.R206H in 12 of 14 Fibrodysplasia Ossificans Progressiva (FOP)patients. One of the remaining patients had a previously reported allele c.1067G>A; p.G356D in the 9th exon and the second allele c.983G>A; p.G328E in the 8th exon of ACVR1."}, {"pubmed": 26097044, "text": "A report of two patients has been presented with multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva caused by the ACVR1 c.772G>A; R258G mutation."}, {"pubmed": 26133550, "text": "Changes in the binding site residue(e.g. pre-hinge region in ALK2) or side chain orientation (e.g. Tyr219 in caALK2 vs. wtALK2), or ligand modification (e.g. DMH1 vs. LDN193189) causes distinct binding profiles and selectivity among BMP inhibitors."}, {"pubmed": 26597752, "text": "The higher PE activin A concentrations resulted in abnormal endothelial functions, which may contribute to the systemic maternal vascular endothelial cell dysfunction observed in the disorder."}, {"pubmed": 26621707, "text": "Fibrodysplasia ossificans progressiva-ACVR1 abnormally transduces bone morphogenetic protein signaling in response to Activin-A."}, {"pubmed": 26776312, "text": "Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders."}, {"pubmed": 26869672, "text": "Activin-A is increased in the airway of asthmatics and peaks during asthma exacerbations.Activin-A signalling pathways are dysregulated in severe asthma."}, {"pubmed": 27182040, "text": "The clinical manifestations, the disease course, and the molecular findings of involvement of ACVR1 gene in this family are suggestive of \"FOP variant\" or an unusual ACVR1-related skeletal dysplasia"}, {"pubmed": 27256111, "text": "Fibrodysplasia ossificans progressiva (FOP) syndrome is caused by mutation of the gene ACVR1. Developed is a simplified one-step procedure by simultaneously introducing reprogramming and gene-editing components into human fibroblasts derived from patient with FOP. The one-step-mediated ALK2 gene-corrected induced pluripotent stem cells restored global gene expression pattern."}, {"pubmed": 27530160, "text": "The ACVR1 R206H mutation may not directly increase the formation of mature chondrogenic or osteogenic cells."}, {"pubmed": 27565519, "text": "The effects of ACVR1/ALK2 mutations causing fibrodysplasia ossificans progressiva are extended to the central nervous system. Brainstem hamartomatous lesions and dysmorphisms, variably associated with dentate nucleus and basal ganglia signal abnormalities and/or calcifications, may represent useful disease hallmarks."}, {"pubmed": 27713089, "text": "the Fibrodysplasia Ossificans Progressiva mutation ACVR1(R206H) is more sensitive to a number of natural ligands."}, {"pubmed": 27959431, "text": "Further investigation on clinical ESCC samples and non-tumorous adjacent tissue found that tumors with triple-positive BMP6, ALK2 and BMPRII had deeper growth than tumors with only BMP6 expression"}, {"pubmed": 28075462, "text": "Low ALK2 expression is associated with invasiveness of breast cancer."}, {"pubmed": 28459464, "text": "Authors demonstrated that the BMP type I receptor ALK-2 (encoded by the ACVR1 gene) has crucial roles in apoptosis induction of patient-derived glioma-initiating cells (GICs), TGS-01 and TGS-04."}, {"pubmed": 28476747, "text": "The role of an ALK2 mutation (R258S) in IRIDA development in a patient also bearing compound heterozygous mutations in TMPRSS6 was demonstrated by reconstructing in vitro the proband's genotype, expressing mutants TMPRSS6 and ACVR1 in the presence of hemojuvelin and assessing hepcidin activation. ALK2(R258S) maintained high hepcidin expression in the presence of MT2(I212T)."}, {"pubmed": 28646109, "text": "Data suggest BMP9/GDF2 and BMP10 synergize with TNFA to increase monocyte recruitment to vascular endothelial cells; process appears to be mediated mainly via ALK2/ACVR1 (which exhibits protein kinase activity). These studies used in vitro flow monocyte adhesion assay. (BMP9 = growth differentiation factor 2; BMP10 = bone morphogenetic protein 10; TNFA = tumor necrosis factor alpha; ALK2/ACVR1 = activin A receptor type 1)"}, {"pubmed": 28733457, "text": "both bone morphogenetic protein 2 (BMP2) and BMP6 are proangiogenic in vitro and ex vivo and that the BMP type I receptors, activin receptor-like kinase 3 (ALK3) and ALK2, play crucial and distinct roles in this process."}, {"pubmed": 28847510, "text": "activation of AMPK upregulated Smad6 and Smurf1 and thereby enhanced their interactions, resulting in its proteosome-dependent degradation of ALK2."}, {"pubmed": 29551750, "text": "this study characterized the ALK2 mutants R258G, G328V and F246Y, which were identified in patients with severe fibrodysplasia ossificans progressiva, diffuse intrinsic pontine glioma and unusual hereditary skeletal dysplasia, respectively."}, {"pubmed": 29587443, "text": "Study emphasizes about the role of ACVR1 which encoding a receptor for BMP proteins in fibrodysplasia ossificans progressiva (FOP). Most FOP patients carry the recurrent R206H substitution in the GS domain, whereas a few other mutations are responsible for limited cases. Mutations cause a dysregulation of the downstream BMP-dependent pathway making mutated ACVR1 responsive to a non-canonical ligand, Activin A. [review]"}, {"pubmed": 29693185, "text": "Results showed that ACVR1 was a direct target of miR-384 and was involved in the inhibitory effects of miR-384 on breast cancer progression. Furthermore, the study indicated that ACVR1 activated the Wnt/beta-catenin signaling pathway in breast cancer."}, {"pubmed": 29739878, "text": "BMPR2 inhibits ALK2-mediated signaling by preventing ALK2 from oligomerizing with the type 2 receptors ACVR2A and ACVR2B."}, {"pubmed": 30159679, "text": "Identification of small molecule inhibitors of ALK2: a virtual screening, density functional theory, and molecular dynamics simulations study."}, {"pubmed": 30819221, "text": "AFAP1-AS1 functions as an endogenous RNA by competitively binding to miR-384 to regulate ACVR1, thus conferring inhibitory effects on pancreatic cancer cell stemness and tumorigenicity"}, {"pubmed": 31240838, "text": "We applied the same modeling and simulation methods to established Fibrodysplasia ossificans progressiva (FOP) variants, to identify the detailed effects that they have on the ACVR1 protein, as well as to act as positive controls against which the effects of p.K400E could be evaluated. Our in silico molecular analyses support p.K400E as altering the behavior of ACVR1"}, {"pubmed": 31432174, "text": "the role of ALK2 in the process of Heterotopic ossification (HO) is introduced and the progress made towards the targeted inhibition of ALK2 is discussed. The present study aims to offer a platform for further research on possible targets for the prevention and treatment of HO."}, {"pubmed": 31685442, "text": "These findings suggest that the PSMD14-ALK2 axis plays an essential role in initiation of the BMP6 signaling pathway and contributes to tumorigenesis and chemoresistance of colorectal cancers."}, {"pubmed": 32142668, "text": "Pediatric glioma mutation Acvr1(G328V) arrests the differentiation of oligodendroglial lineage cells, and cooperates with Hist1h3b(K27M) and Pik3ca(H1047R) to generate high-grade diffuse gliomas."}, {"pubmed": 32235336, "text": "Activins as Dual Specificity TGF-beta Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors."}, {"pubmed": 32273545, "text": "Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TbetaRI cross-talk in diffuse intrinsic pontine glioma."}, {"pubmed": 32437875, "text": "Functional characterization of a unique mutant of ALK2, p.K400E, that is associated with a skeletal disorder, diffuse idiopathic skeletal hyperostosis."}, {"pubmed": 32448372, "text": "Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1."}, {"pubmed": 32473755, "text": "Involvement of activin a receptor type 1 (ACVR1) in the pathogenesis of primary focal hyperhidrosis."}, {"pubmed": 32512165, "text": "Design of primers for direct sequencing of nine coding exons in the human ACVR1 gene."}, {"pubmed": 32641001, "text": "Association analysis of polymorphisms rs12997 in ACVR1 and rs1043784 in BMP6 genes involved in bone morphogenic protein signaling pathway in primary angle-closure and pseudoexfoliation glaucoma patients of Saudi origin."}, {"pubmed": 33089331, "text": "A Three-Generation Pedigree of Multifocal Heterotopic Ossification With Bilateral Involvement."}, {"pubmed": 33443061, "text": "Association of rs12997 variant in the ACVR1 gene: a member of bone morphogenic protein signaling pathway with primary open-angle glaucoma in a Saudi cohort."}, {"pubmed": 33766507, "text": "MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1."}, {"pubmed": 33973349, "text": "Nonclassic fibrodysplasia ossificans progressiva: A child from Angola with an ACVR1(G328E) variant."}, {"pubmed": 34003511, "text": "Pathogenic ACVR1(R206H) activation by Activin A-induced receptor clustering and autophosphorylation."}, {"pubmed": 34013359, "text": "Anti-Mullerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival."}, {"pubmed": 34311122, "text": "ACVR1(R206H) extends inflammatory responses in human induced pluripotent stem cell-derived macrophages."}, {"pubmed": 34400635, "text": "Structural basis for ALK2/BMPR2 receptor complex signaling through kinase domain oligomerization."}, {"pubmed": 34490965, "text": "Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2."}, {"pubmed": 34755602, "text": "Modeling the ACVR1(R206H) mutation in human skeletal muscle stem cells."}, {"pubmed": 34854557, "text": "An ACVR1(R375P) pathogenic variant in two families with mild fibrodysplasia ossificans progressiva."}, {"pubmed": 35236255, "text": "MicroRNA-137 inhibits the inflammatory response and extracellular matrix degradation in lipopolysaccharide-stimulated human nucleus pulposus cells by targeting activin a receptor type I."}, {"pubmed": 35587280, "text": "Recurrent ACVR1 mutations in posterior fossa ependymoma."}, {"pubmed": 36003055, "text": "Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting."}, {"pubmed": 36131296, "text": "Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs."}, {"pubmed": 36606464, "text": "Functional comparison of human ACVR1 and zebrafish Acvr1l FOP-associated variants in embryonic zebrafish."}, {"pubmed": 36717825, "text": "FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells."}, {"pubmed": 37231012, "text": "A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders."}, {"pubmed": 37759764, "text": "AAV-Mediated Targeting of the Activin A-ACVR1[R206H] Signaling in Fibrodysplasia Ossificans Progressiva."}, {"pubmed": 38229201, "text": "BMP-ACVR1 Axis is Critical for Efficacy of PRC2 Inhibitors in B-Cell Lymphoma."}, {"pubmed": 38557054, "text": "BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension."}], "genomic_pos": {"chr": "2", "end": 157876330, "ensemblgene": "ENSG00000115170", "start": 157736251, "strand": -1}, "genomic_pos_hg19": {"chr": "2", "end": 158732374, "start": 158592958, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001569", "qualifier": "involved_in", "term": "branching involved in blood vessel morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001701", "qualifier": "involved_in", "term": "in utero embryonic development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001702", "qualifier": "involved_in", "term": "gastrulation with mouth forming second"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001707", "qualifier": "involved_in", "term": "mesoderm formation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001755", "qualifier": "involved_in", "term": "neural crest cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002526", "qualifier": "involved_in", "term": "acute inflammatory response"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0003143", "pubmed": 19506109, "qualifier": "involved_in", "term": "embryonic heart tube morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0003148", "qualifier": "NOT involved_in", "term": "outflow tract septum morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0003181", "qualifier": "involved_in", "term": "atrioventricular valve morphogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0003183", "pubmed": 19506109, "qualifier": "involved_in", "term": "mitral valve morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0003272", "qualifier": "involved_in", "term": "endocardial cushion formation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0003274", "qualifier": "involved_in", "term": "endocardial cushion fusion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0003289", "pubmed": 19506109, "qualifier": "involved_in", "term": "atrial septum primum morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0003289", "qualifier": "involved_in", "term": "atrial septum primum morphogenesis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006468", "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007179", "qualifier": "involved_in", "term": "transforming growth factor beta receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007179", "pubmed": 8242742, "qualifier": "involved_in", "term": "transforming growth factor beta receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007281", "qualifier": "involved_in", "term": "germ cell development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007368", "qualifier": "involved_in", "term": "determination of left/right symmetry"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007507", "qualifier": "involved_in", "term": "heart development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009953", "qualifier": "involved_in", "term": "dorsal/ventral pattern formation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0009968", "pubmed": 9884026, "qualifier": "involved_in", "term": "negative regulation of signal transduction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030278", "pubmed": 16642017, "qualifier": "involved_in", "term": "regulation of ossification"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0030335", "pubmed": 19736306, "qualifier": "involved_in", "term": "positive regulation of cell migration"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030501", "pubmed": 18436533, "qualifier": "involved_in", "term": "positive regulation of bone mineralization"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030509", "qualifier": "involved_in", "term": "BMP signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030509", "pubmed": [12065756, 18436533], "qualifier": "involved_in", "term": "BMP signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030509", "qualifier": "involved_in", "term": "BMP signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032924", "pubmed": 19506109, "qualifier": "involved_in", "term": "activin receptor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032924", "pubmed": 18326817, "qualifier": "involved_in", "term": "activin receptor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032926", "pubmed": 9884026, "qualifier": "involved_in", "term": "negative regulation of activin receptor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045669", "pubmed": 18436533, "qualifier": "involved_in", "term": "positive regulation of osteoblast differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045893", "pubmed": 8242742, "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 19506109, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045944", "pubmed": 18326817, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050731", "pubmed": 26598555, "qualifier": "involved_in", "term": "positive regulation of peptidyl-tyrosine phosphorylation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051145", "qualifier": "involved_in", "term": "smooth muscle cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060037", "qualifier": "involved_in", "term": "pharyngeal system development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060391", "pubmed": [19506109, 19736306], "qualifier": "involved_in", "term": "positive regulation of SMAD protein signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060391", "qualifier": "involved_in", "term": "positive regulation of SMAD protein signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060412", "qualifier": "involved_in", "term": "ventricular septum morphogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060923", "pubmed": 19506109, "qualifier": "involved_in", "term": "cardiac muscle cell fate commitment"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0061445", "pubmed": 19506109, "qualifier": "involved_in", "term": "endocardial cushion cell fate commitment"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0062043", "qualifier": "involved_in", "term": "positive regulation of cardiac epithelial to mesenchymal transition"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0071363", "qualifier": "involved_in", "term": "cellular response to growth factor stimulus"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0071773", "pubmed": 18326817, "qualifier": "involved_in", "term": "cellular response to BMP stimulus"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:2000017", "pubmed": 19506109, "qualifier": "involved_in", "term": "positive regulation of determination of dorsal identity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2000134", "pubmed": 9884026, "qualifier": "involved_in", "term": "negative regulation of G1/S transition of mitotic cell cycle"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2001237", "pubmed": 9884026, "qualifier": "involved_in", "term": "negative regulation of extrinsic apoptotic signaling pathway"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 8242742, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0045177", "qualifier": "located_in", "term": "apical part of cell"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0048179", "pubmed": 8242742, "qualifier": "part_of", "term": "activin receptor complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0070724", "qualifier": "part_of", "term": "BMP receptor complex"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0004672", "pubmed": 19736306, "qualifier": "enables", "term": "protein kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004674", "pubmed": 12065756, "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004675", "pubmed": [19506109, 19736306], "qualifier": "enables", "term": "transmembrane receptor protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "NAS", "id": "GO:0004675", "pubmed": 8242742, "qualifier": "enables", "term": "transmembrane receptor protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005025", "qualifier": "enables", "term": "transforming growth factor beta receptor activity, type I"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [8242742, 8555189, 11266516, 18436533, 21791611, 31483918], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005524", "pubmed": 12065756, "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016361", "pubmed": 8242742, "qualifier": "contributes_to", "term": "activin receptor activity, type I"}, {"category": "MF", "evidence": "NAS", "id": "GO:0017046", "pubmed": 12702211, "qualifier": "enables", "term": "peptide hormone binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042803", "pubmed": 18436533, "qualifier": "enables", "term": "protein homodimerization activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0045296", "pubmed": 26598555, "qualifier": "enables", "term": "cadherin binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0046332", "qualifier": "enables", "term": "SMAD binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0046332", "pubmed": 12065756, "qualifier": "enables", "term": "SMAD binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0048185", "pubmed": 8242742, "qualifier": "enables", "term": "activin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0050431", "pubmed": 8242742, "qualifier": "enables", "term": "transforming growth factor beta binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0098821", "pubmed": 12065756, "qualifier": "enables", "term": "BMP receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:1990782", "pubmed": 26598555, "qualifier": "enables", "term": "protein tyrosine kinase binding"}]}, "homologene": {"genes": [[7165, 1269509], [7227, 35731], [7955, 30615], [8364, 550111], [9031, 395246], [9544, 697935], [9598, 470565], [9606, 90], [9615, 478757], [9913, 338068], [10090, 11477], [10116, 79558]], "id": 7}, "interpro": [{"desc": "Activin types I and II receptor domain", "id": "IPR000472", "short_desc": "Activin_recp"}, {"desc": "Snake toxin-like superfamily", "id": "IPR045860", "short_desc": "Snake_toxin-like_sf"}, {"desc": "Ser/Thr protein kinase, TGFB receptor", "id": "IPR000333", "short_desc": "TGFB_receptor"}, {"desc": "Protein kinase domain", "id": "IPR000719", "short_desc": "Prot_kinase_dom"}, {"desc": "Serine-threonine/tyrosine-protein kinase, catalytic domain", "id": "IPR001245", "short_desc": "Ser-Thr/Tyr_kinase_cat_dom"}, {"desc": "GS domain", "id": "IPR003605", "short_desc": "GS_dom"}, {"desc": "Serine/threonine-protein kinase, active site", "id": "IPR008271", "short_desc": "Ser/Thr_kinase_AS"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "Protein kinase, ATP binding site", "id": "IPR017441", "short_desc": "Protein_kinase_ATP_BS"}], "ipi": ["IPI00029219", "IPI00917000", "IPI00917175", "IPI00917815", "IPI01011207"], "map_location": "2q24.1", "name": "activin A receptor type 1", "other_names": ["TGF-B superfamily receptor type I", "activin A receptor, type I", "activin A receptor, type II-like kinase 2", "activin receptor type I", "activin receptor type-1", "activin receptor-like kinase 2", "hydroxyalkyl-protein kinase", "serine/threonine-protein kinase receptor R1"], "pantherdb": {"HGNC": "171", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "87911", "ortholog_type": "LDO", "panther_family": "PTHR23255", "taxid": 10090, "uniprot_kb": "P37172"}, {"RGD": "620200", "ortholog_type": "LDO", "panther_family": "PTHR23255", "taxid": 10116, "uniprot_kb": "P80201"}, {"Gene": "ACVR1", "ortholog_type": "LDO", "panther_family": "PTHR23255", "taxid": 9031, "uniprot_kb": "Q90ZK6"}, {"Ensembl": "ENSGALG00000037301", "ortholog_type": "LDO", "panther_family": "PTHR23255", "taxid": 9031, "uniprot_kb": "A0A1D5P2D8"}, {"ZFIN": "ZDB-GENE-990415-9", "ortholog_type": "O", "panther_family": "PTHR23255", "taxid": 7955, "uniprot_kb": "O73736"}, {"FlyBase": "FBgn0003317", "ortholog_type": "O", "panther_family": "PTHR23255", "taxid": 7227, "uniprot_kb": "A0A0B4K7J3"}], "uniprot_kb": "Q04771"}, "pathway": {"kegg": [{"id": "hsa04060", "name": "Cytokine-cytokine receptor interaction - Homo sapiens (human)"}, {"id": "hsa04350", "name": "TGF-beta signaling pathway - Homo sapiens (human)"}, {"id": "hsa04550", "name": "Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human)"}, {"id": "hsa05418", "name": "Fluid shear stress and atherosclerosis - Homo sapiens (human)"}], "pid": [{"id": "alk1pathway", "name": "ALK1 signaling events"}, {"id": "alk2pathway", "name": "ALK2 signaling events"}], "wikipathways": [{"id": "WP2857", "name": "Mesodermal commitment pathway"}, {"id": "WP3931", "name": "ESC Pluripotency Pathways"}]}, "pdb": ["3H9R", "3MTF", "3OOM", "3Q4U", "4BGG", "4C02", "4DYM", "5OXG", "5OY6", "5S75", "5S76", "5S77", "5S78", "5S79", "5S7A", "5S7B", "5S7C", "5S7D", "5S7E", "5S7F", "5S7G", "5S7H", "5S7I", "5S7J", "5S7K", "5S7L", "5S7M", "5S7N", "5S7O", "5S7P", "5S7Q", "5S7R", "5S7S", "5S7T", "5S7U", "5S7V", "5S7W", "5S7X", "5S7Y", "5S7Z", "5S80", "5S81", "5S82", "5S83", "5S84", "5S85", "5S86", "5S87", "5S88", "5S89", "5S8A", "5S8B", "5S9K", "6ACR", "6EIX", "6GI6", "6GIN", "6GIP", "6I1S", "6JUX", "6SRH", "6SZM", "6T6D", "6T8N", "6TN8", "6UNQ", "6UNR", "6UNS", "6Z36", "6ZGC", "7A21", "7C3G", "7NNS", "7YRU", "8C7W", "8C7Z", "8R7G"], "pfam": ["PF01064", "PF07714", "PF08515", "PF00069"], "pharmgkb": "PA24492", "pharos": {"target_id": 15582, "tdl": "Tchem"}, "pir": "A45992", "prosite": ["PS50011", "PS51256"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF245299", "relationship": "is"}, {"id": "GNF245300", "relationship": "is"}, {"id": "GNF245301", "relationship": "is"}, {"id": "GNF245302", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF162955", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF033692", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF079183", "relationship": "is"}, {"id": "GNF079184", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050566", "relationship": "is"}, {"id": "GNF055329", "relationship": "is"}, {"id": "GNF059944", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069093", "relationship": "is"}, {"id": "GNF069094", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": [{"id": "GNF165292", "relationship": "is"}, {"id": "GNF165293", "relationship": "is"}, {"id": "GNF165294", "relationship": "is"}, {"id": "GNF165295", "relationship": "is"}], "GNF_hs_LentiORF-HA-MYC": {"id": "GNF283105", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF284032", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF000180", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF244541", "relationship": "is"}, "Invitrogen_IVTHSSIPKv2": [{"id": "GNF324730", "relationship": "is"}, {"id": "GNF324731", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF093040", "relationship": "is"}, {"id": "GNF132738", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1", "NG_008004.1"], "protein": ["NP_001096.1", "NP_001104537.1", "NP_001334592.1", "NP_001334593.1", "NP_001334594.1", "NP_001334595.1", "NP_001334596.1"], "rna": ["NM_001105.5", "NM_001111067.4", "NM_001347663.1", "NM_001347664.1", "NM_001347665.1", "NM_001347666.1", "NM_001347667.2"], "translation": [{"protein": "NP_001334593.1", "rna": "NM_001347664.1"}, {"protein": "NP_001334594.1", "rna": "NM_001347665.1"}, {"protein": "NP_001104537.1", "rna": "NM_001111067.4"}, {"protein": "NP_001334592.1", "rna": "NM_001347663.1"}, {"protein": "NP_001334595.1", "rna": "NM_001347666.1"}, {"protein": "NP_001096.1", "rna": "NM_001105.5"}, {"protein": "NP_001334596.1", "rna": "NM_001347667.2"}]}, "reporter": {"HG-U133_Plus_2": "203935_at", "HG-U95Av2": "39764_at", "HTA-2_0": "TC02002455.hg.1", "HuEx-1_0": "2582562", "HuGene-1_1": "8056005", "HuGene-2_1": "16903969"}, "retired": 50946, "summary": "Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008].", "symbol": "ACVR1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1332012"}, "unigene": "Hs.470316", "uniprot": {"Swiss-Prot": "Q04771", "TrEMBL": ["C9JW28", "D3DPA4", "C9JHJ7", "A0A804HHZ2", "A0A1B0GXA9", "A0A804HJQ0"]}, "wikipedia": {"url_stub": "ACVR1"}}